Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
BCDA
BioCardia Inc.
$1.36
Login to see BioCardia Inc. (BCDA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Chart
$2.27 (-40.09%)
$2.33 (-41.63%)
$2.9 (-53.10%)
$2.69 (-49.44%)
BCDA has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Price under $5
High volatilty
BCDA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
BCDA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BCDA Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayBCDA Earnings
The TTM reflects 12-month period, providing review of BCDA financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is BCDA current stock price?
What are BCDA stock strengths?
What risks are associated with BCDA stock?
When is BCDA next earnings report?
What is BCDA market cap and volume?
What is BCDA's current Stock IQ?
Should I buy BCDA stock right now?
Is BCDA a Strong Buy right now?
What does a 'Strong Buy' rating mean for BCDA?
What does a 'Strong Sell' rating mean for BCDA?
What factors influence BCDA's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
BCDA
BioCardia Inc.
Current Price
$1.36
Login to unlock BioCardia Inc. (BCDA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$2.27 (-40.09%)
$2.33 (-41.63%)
$2.9 (-53.10%)
$2.69 (-49.44%)
BCDA Analysts Opinion
BCDA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
BCDA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BCDA Street view is extremely bullish and have positive views on the near-term outlook
BCDA has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Price under $5
High volatilty
Average key support and resistance price levels.
Login to displayBCDA Earnings
The TTM data reflects the most recent 12-month period, providing overview of BCDA financial performance.
BCDA Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
BCDA Latest Analysis
BioCardia regains Nasdaq compliance after balance sheet improvements. shares up.
Thu Oct 2, 2025
BioCardia (BCDA) Price Target Increased by 158.33% to 15.81. The average one-year price target for BioCardia (NasdaqCM:BCDA) has been revised to $15.81 / share. This is an increase of 158.33% from the prior estimate of $6.12 dated September 10 2025. The price target is an average of many targets provided by analysts. T
Tue Sep 30, 2025
BioCardia announces pricing of up to $12M public offering.
Thu Sep 18, 2025
BioCardia Announces Pricing of Up To $12 Million Public Offering. ®. Inc. (NASDAQ:) (BioCardia or the Company) a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announced the pricing of a public offering of an aggregate of 4800000 shares of its common stock and short-term warrants to purchase up to 4800000 shares of common stock at a combined public offering price of $1.25 per share and accompanying short-term warrant. The
Thu Sep 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BCDA Stock trends
BCDA Stock performance
BCDA Stock analysis
BCDA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings